HEALTH● LOWAug 1 · Aug 1, 2026, 11:00 AM
FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
NPR News
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoWhy people who have never smoked become addicted to e-cigarettesBBC AfriqueHEALTH2h ago‘Really terrified’: how a blood test could spare cancer patients an agonising waitSouth China Morning PostHEALTH2h agoRed Cross trains staff as Kenya records its second death from EbolaAfricanews [en]HEALTH2h agoCongo begins Ebola vaccine trial despite embedded outbreakSouth China Morning Post